Association of postpartum hypocalcemia with early-lactation milk yield, reproductive performance, and culling in dairy cows

Association of different classifications of hypocalcemia with quantity and quality of colostrum, milk production, and health of Holstein dams and their calves

The aim of the present study was to assess the effect of serum calcium (Ca) status in the early postpartum period on the quantity and quality of colostrum, milk production, and the health of Holstein dams and their calves. One hundred multiparous Holstein cows were enrolled in this study. To determine serum Ca status, blood samples were taken at 1 and 4 days in milk (DIM). Cows were categorized into 1 of 4 groups based on their serum Ca concentrations: normocalcemic (CON; Ca >1.87 at 1 DIM and >2.10 mmol/L at 4 DIM, n = 36), transient SCH (TSCH; Ca ≤1.87 at 1 DIM and >2.10 mmol/L at 4 DIM, n = 14), persistent SCH (PSCH; Ca ≤1.87 at 1 DIM and ≤2.10 mmol/L at 4 DIM, n = 15), or delayed SCH (DSCH; Ca >1.87 at 1 DIM and ≤2.10 mmol/L at 4 DIM, n = 35). The ROC curve was utilized to determine the optimal cut-off value for serum total Ca, maximizing both sensitivity and specificity in predicting metritis. Metabolic disorders such as dystocia, retained placenta, and culling within 60 DIM were not affected by serum Ca status in the early postpartum period (P > 0.10). However, the incidences of metritis and endometritis were different based on the serum Ca status of the cows. The PSCH cows had a higher incidence of metritis than the CON cows (P = 0.05). Also, the DSCH cows tended to have an increased risk of metritis than the CON cows (P = 0.09). However, metritis incidence in the TSCH and CON cows was similar (P = 0.83). Cows with PSCH (P = 0.07) and DSCH (P = 0.10) tended to be at a higher risk for endometritis than the CON cows. But, the incidence of endometritis in the TSCH and CON cows was not different (P = 0.50). The TSCH cows had higher milk yield than the PSCH and DSCH cows (P = 0.05). However, milk yield was not different between the TSCH and CON cows and the PSCH and DSCH and CON cows. The serum Ca status of cows had no effect on colostrum volume and its quality, age and weight of weaning, and average daily gain of calves (P > 0.10). The proportion of calves experiencing failure of passive transfer (FPT) was greater in the PSCH group than in the CON group (P = 0.03). Also, the FPT tended to be higher in the DSCH calves compared to the CON calves (P = 0.10). However, the FPT in the TSCH and CON calves was not different (P = 0.83). The incidence of diarrhea tended to be higher in the PSCH and DSCH calves compared to the CON calves (P = 0.10). However, diarrhea incidence between the TSCH and CON calves was similar (P = 0.97). Overall, the findings of this study suggest that cows with TSCH showed better adaptation to lactation, experienced a lower occurrence of diseases and produced higher milk compared to PSCH and DSCH cows. Furthermore, despite the similar quantity and quality of colostrum across all groups, the PSCH and DSCH groups displayed a greater proportion of calves experiencing FPT and diarrhea in comparison to the TSCH group.

The Transcript Levels and the Serum Profile of Biomarkers Associated with Clinical Endometritis Susceptibility in Buffalo Cows

Determining the gene expression and serum profile of the indicators linked to clinical endometritis susceptibility in Egyptian buffalo cows was the aim of this investigation. The buffalo cows that were enrolled were divided into two groups: forty infected buffalo cows with clinical endometritis and forty seemingly healthy buffalo cows that served as the control group. For the purposes of gene expression and biochemical analysis, ten milliliters of blood was obtained via jugular venipuncture from each buffalo cow. TLR4, IL-8, IL-17, NFKB, SLCA11A1, NCF4, Keap1, HMOX1, OXSR1, ST1P1, and SERP1 were manifestly expressed at much higher levels in the buffaloes with endometritis. On the other hand, the genes that encode SOD, CAT, NDUFS6, Nrf2, and PRDX2 were down-regulated. There was a significant (p < 0.05) elevation of the serum levels of non-esterified fatty acids (NEFAs), beta hydroxy butyric acid (BHBA), triglycerides (TGs), globulin, creatinine, and cortisol, along with a reduction in the serum levels of glucose, cholesterol, total protein albumin, urea, estrogen (E2), progesterone (P4), follicle-stimulating hormone (FSH), luteinizing hormone (LH), thyroxine (T4), prostaglandin F2 α (PGF2α), calcium, iron, and selenium, in the endometritis group in comparison with the control. However, no significant change was observed in the values of phosphorus, magnesium, copper, or zinc in either group. Within the selective breeding of naturally resistant animals, the variation in the genes under study and the changes in the serum profiles of the indicators under investigation may serve as a reference guide for reducing endometritis in Egyptian buffalo cows.

Effects of feeding difructose anhydride on the mineral status and milking performance of transition cows

The objective of this study was to assess the potential effect of difructose anhydride III (DFAIII) on calcemia, magnesemia, and milking performance in dairy cows. A total of 66 multiparous Holstein cows in late pregnancy (gestation days, mean ± SD = 253.8 ± 2.13 d) were blocked according to their expected calving date and randomly assigned to either receiving no supplementation (control) or receiving 40 g/d of DFAIII (DFA) between -14 and +7 d relative to calving following a complete randomized block design. Cows in the control group received 640 g/d of a pellet containing no DFAIII, whereas DFA cows received the same pellet but containing 6.25% DFAIII. Pellets of each treatment were top-dressed on a daily basis while cows were dry and were fed via an automatic feeding system twice daily (320 g each feeding) during milking. Dry cows were fed once a day, whereas lactating cows were fed twice daily. Dry matter intake was individually monitored on a daily basis. Cows were milked twice daily and milk production and milk protein and fat contents recorded at every milking. Cows were kept on the study until they reached 21 d postpartum. Cows were weighed at dry-off (∼45 d before study enrollment) and twice daily after calving at the exit of the milking parlor. Cows were blood sampled for subsequent determination of serum Ca and Mg concentrations 3 d before the expected calving date and at 6, 12, 24, and 48 h and 7 and 14 d after calving. We found no differences in DMI before calving, but DFA cows consumed more feed than control cows at ∼15 DIM. All cows lost BW after calving, but DFA cows lost slightly less BW during the first 5 DIM than control cows. Cows on DFAIII produced more milk at ∼10 DIM compared with control cows, and DFAIII cows produced more milk protein than control cows 3 d after calving. Serum Ca concentrations were not affected by DFAIII supplementation; however, serum Mg concentrations at 6, 12, and 24 h after calving were greater in DFA than in control cows. In all, DFAIII did not affect postpartum calcemia but improved magnesemia between 6 and 24 h after calving. Milk production in DFA cows was improved around 10 d after calving and milk protein yield after 3 d postpartum compared with control cows. The mechanism leading to increased Mg availability is not clear and warrants further research.

Does knowledge of blood calcium concentration at 2 days postpartum affect decisions of calcium supplementation?

Delaying oral Ca supplementation might benefit cows with low blood Ca concentrations at 4 d in milk (DIM), a time when reduced blood total Ca (tCa) is associated with negative health and production outcomes. To implement a targeted approach to manage subclinical hypocalcemia (SCH) at the herd level, it is important to identify which cows benefit from supplemental Ca. Therefore, our objective was to determine if SCH diagnosis at 2 DIM could inform decisions of oral Ca supplementation at 2 and 3 DIM based on milk yield and 4 DIM blood Ca concentration. Data were analyzed from a previously conducted randomized controlled trial on multiparous cows (n = 518) from 4 farms in New York State. Cows were randomly assigned to 1 of 2 treatment groups at calving: (1) control (CON; no Ca supplementation, n = 259) or (2) bolus (BOL; 43 g of oral Ca administered at 2 and 3 DIM postcalving, n = 259). For each parity group (2, 3, 4+), we used generalized linear mixed models to identify serum tCa concentrations at 2 DIM that maximized the difference in milk yield to diagnose SCH. Cows were classified as normocalcemic (NC; parity 2 tCa >1.9 mmol/L, parity 3 tCa >1.87 mmol/L, n = 327; parity ≥4 had no defining threshold) or SCH (parity 2 tCa ≤1.9 mmol/L, parity 3 tCa ≤1.87 mmol/L, n = 58; parity ≥4 had no defining threshold). Parity 2 and 3 cows were further classified into 1 of 4 SCH-treatment groups (SCHTRT) based on 2 DIM SCH status and random treatment allocation: (1) NC-CON, n = 165, (2) SCH-CON, n = 28, (3) NC-BOL, n = 162, or (4) SCH-BOL, n = 30. Generalized linear mixed models were used to analyze the difference in milk yield for the first 10 wk of lactation and tCa at 4 DIM between SCHTRT groups with separate analyses performed for parities 2 and 3. Mean milk yield differed between SCHTRT groups for both parities. For parity 2, SCH-CON and SCH-BOL cows produced more milk than NC-CON and NC-BOL cows with SCH-CON producing 50.9 (95% confidence interval [CI] = 48.4, 53.4) kg/d, SCH-BOL 51.7 (49.1, 54.2) kg/d, NC-CON 47.5 (46.3, 48.7) kg/d, and NC-BOL 47.2 (45.8, 48.5) kg/d of milk. Milk yield was also different between SCHTRT groups for parity 3 with SCH-BOL cows producing more milk than NC-CON and NC-BOL cows. In parity 3, SCH-BOL cows produced 56.3 (95% CI = 53.1, 59.3) kg/d, SCH-CON 51.7 (48.6, 54.7) kg/d, NC-BOL 50.6 (49.0, 52.2) kg/d, and NC-CON 48.7 (46.9, 50.5) kg/d of milk. For both parities, SCH-CON and SCH-BOL cows had lower tCa at 2 DIM than NC-CON and NC-BOL cows. At 4 DIM, tCa concentrations were similar for all SCHTRT groups respective to parity. Our results suggest that although delayed Ca bolus administration does not improve blood Ca concentration when compared with controls, it does support increased milk production in parity 3 cows regardless of Ca status at 2 DIM. Thus, knowledge of blood Ca at 2 DIM should not affect decisions of Ca supplementation in this parity of cows.

Associations of postpartum health with progesterone after insemination and endocrine signaling during early pregnancy in dairy cows

Our objective was to investigate associations of postpartum health with serum progesterone (P4) concentrations after first artificial insemination (AI), expression of interferon-stimulated genes (ISG) in blood leukocytes, and serum pregnancy-associated glycoprotein (PAG) during early pregnancy in dairy cows. In this observational study, Holstein cows (n = 475) from 2 commercial herds were enrolled 3 wk before expected parturition. Body condition score (BCS) and lameness were assessed at enrollment, and total Ca, haptoglobin, and nonesterified fatty acids (NEFA) were measured in serum at 2 and 6 ± 2 d in milk (DIM). Blood β-hydroxybutyrate and metritis were evaluated at 4, 8, 11, and 15 ± 2 DIM, and purulent vaginal discharge (PVD) and endometritis based on endometrial cytology were diagnosed at 35 DIM. Onset of cyclicity was assessed by biweekly P4 measurements. The BCS was assessed at enrollment and at 63 DIM, and lameness at enrollment and at 21 and 49 DIM. First AI was based on estrus detection until ∼75 DIM, or synchronization for timed AI thereafter. Serum P4 was measured at d 8 and 12 after first AI; expression of ISG (ISG15 and RTP4) in blood leukocytes was assessed at d 19; and PAG in serum of pregnant cows was measured at d 29, 33, and 40. Multivariable linear regression models were built including health variables (with metabolites categorized via receiver operating characteristic curve analysis) and covariates (season, milk yield, AI method, DIM), accounting for pregnancy status (for ISG and PAG models), repeated measures (for P4 and PAG models), and herd as random. Results are reported comparing cows affected versus unaffected by each predictor. Serum P4 concentrations were lesser at d 8 after AI in cows that had total Ca ≤2.09 mM (3.6 vs. 4.0 ± 0.2 ng/mL) at 2 DIM or a clinical disease (3.7 vs. 4.0 ± 0.2 mg/mL), and P4 tended to be lesser at d 8 in cows that had PVD (3.6 vs. 4.0 ± 0.2 ng/mL) or any uterine disease (3.7 vs. 4.1 ± 0.2 ng/mL). Among cows pregnant at d 29, relative ISG15 expression (fold change) at d 19 was greater in cows that had lameness (5.10 [4.18-6.18] vs. 3.14 [3.10-3.19]) but tended to be lesser in cows that had endometritis (3.20 [2.89-3.54] vs. 4.29 [4.20-4.35]), and relative expression of RTP4 tended to be lesser in cows that had displaced abomasum (1.02 [0.62-1.67] vs. 1.75 [1.73-1.78]). Serum PAG was lesser at d 29 (3.8 vs. 4.2 ± 0.2 sample-to-positive ratio [S:P]) in cows that had NEFA ≥0.73 mM at 6 DIM, and lesser at d 33 (3.9 vs. 4.5 ± 0.2 S:P) and 40 (3.1 vs. 3.7 ± 0.2 S:P) in cows that had prepartum BCS ≥3.75. These findings suggest long-term effects of metabolic or reproductive tract disorders on luteal function after first AI, pregnancy recognition signaling, and placental function during early pregnancy. These associations may partially explain some of the pathways linking postpartum health and fertility in dairy cows.

Effects of oral calcium on reproduction and postpartum health in cattle: a meta-analysis and quality assessment

Postpartum blood calcium (Ca) concentration is related to the reproduction and health of cattle. Oral calcium supplements were given to dairy cows after calving to increase blood Ca concentration and reduce the risk of hypocalcemia. However, studies have shown that oral Ca has different effects in preventing disease. The purposes of this study were (i) to conduct a meta-analysis to evaluate the expected effect of oral Ca on incidence of calving-related diseases, pregnancy risk and milk yield in dairy cows, and (ii) to make a quality assessment of these related studies. In total, 22 eligible studies were included in this review. Meta-analysis showed that oral Ca could significantly reduce the incidence of hypocalcemia (clinical hypocalcemia: relative risk (RR) = 0.67, 95% confidence interval (CI) = [0.52, 0.87]; subclinical hypocalcemia: RR = 0.81, CI = [0.72, 0.91]), and incidence of retained placenta (RR = 0.77, CI = [0.62, 0.95]), improved blood Ca concentrations: mean difference (MD) = 0.08; 95% CI = [0.04, 0.11]. For other results, the meta-analysis revealed a lack of evidence of the correlation between oral Ca and serum magnesium (Mg) / phosphorus (P) concentration (Mg: MD = -0.04; 95% CI = [-0.10, 0.02]; P: MD = 0.05; 95% CI = [-0.10, 0.21]) or incidence of other calving-related disorders (metritis: RR = 1.06, CI = [0.94, 1.19]; ketosis: RR = 1.04, CI = [0.91, 1.18]; mastitis: RR = 1.02, CI = [0.86, 1.21]; displacement of the abomasum: RR = 0.81, CI = [0.57, 1.16]) or pregnancy risk (pregnancy risk at first service: RR = 0.99, CI = [0.94, 1.05]; overall pregnancy rate: RR = 1.03, CI = [0.98, 1.08]) or milk yield (MD = 0.44; 95% CI = [-0.24, 1.13]). The distribution of the funnel plot formed by the included studies was symmetrical, and the Egger's test had a p > 0.05, indicating that there was no significant publication bias. Sensitivity analyses results suggested that the results of meta-analysis are robust. Quality assessment of the included studies revealed that the risk of bias was focused on selection bias, performance bias, detection bias and other sources of bias, and the future research should focus on these aspects.

Effects of timing of oral calcium administration on milk production in high-producing early-lactation Holstein cows

Supplementation of oral Ca via blanket administration of an oral Ca bolus at 0 and 24 h after calving has shown limited success in increasing production and minimizing adverse health events. Recent evidence that reductions in blood Ca at 4 d in milk (DIM) are more closely associated with negative outcomes than hypocalcemia at 0 to 24 h postpartum might explain this lack of Ca bolus efficacy. Therefore, our primary objective was to explore the effect of delayed oral Ca bolus supplementation on milk production, with secondary objectives of exploring the effects on disease incidence and postpartum blood Ca dynamics. We conducted a randomized controlled trial on multiparous Holstein cows (n = 998) from 4 herds in New York. At calving, cows were randomly assigned to 1 of 3 treatment groups: (1) control, no supplemental Ca at or around parturition (CON; n = 343); (2) conventional bolus, an oral Ca bolus containing 43 g of Ca at calving and 24 h later (BOL-C; n = 330); or (3) delayed bolus, an oral Ca bolus containing 43 g of Ca at 48 and 72 h after calving (BOL-D; n = 325). We created generalized linear mixed models to analyze differences in milk yield for the first 10 wk of lactation and serum total Ca (tCa) at 1 and 4 DIM between treatment groups; multivariable Poisson regression models were used to analyze adverse event outcomes (metritis, displaced abomasum, herd removal, or a combination of one or more of the 3) in the first 30 DIM. Milk yield increased by week and was not affected by treatment. However, a treatment by parity group interaction for milk yield showed that BOL-D cows in the third parity produced more milk than third-parity BOL-C or CON cows (BOL-D = 52.0 kg/d, 95% confidence interval [50.6, 53.4] kg/d, BOL-C = 47.9 [46.3, 49.5] kg/d, CON = 49.8 [48.2, 51.2] kg/d). The incidence of adverse health events was similar between treatments (BOL-D = 3.7%, BOL-C = 3.7%, CON = 3.6%). Serum tCa was lower at 1 than 4 DIM, and we detected no difference in tCa between treatment groups. Our findings suggest that delaying oral Ca bolus supplementation has limited influence on blood Ca concentrations but may be beneficial to cohorts of cows as a targeted prophylactic supplement to support milk production.

Biomarkers of oxidative stress and liver function in early lactation and their relationship with the reproductive efficiency of multiparous grazing dairy cows in Argentina. A retrospective study

This study aimed to analyze the possible relationship between days to conception and different oxidative stress (OS) biomarkers and liver functional parameters in multiparous dairy cows. Besides, a fast reliable method for the accurate measurement of malondialdehyde (MDA) by liquid chromatography-tandem mass spectrometry was developed in several matrices. During lactation, the days to conception of 28 cows were determined for a retrospective study. According to this parameter, cows were divided into two groups: high and low days to conception (HDC and LDC, respectively). Blood, urine and liver biopsies were sampled 21 days before the expected calving date, and 7 and 21 days after calving. The method developed for MDA was validated according to international requirements. The lower limit of quantification was 0.25 µmol/L for plasma and urine and 10.00 µmol/L for liver tissue. No differences between groups were observed in the systemic concentration of non-esterified fatty acids, β-hydroxybutyric acid and liver triacylglycerol content (P > 0.05). Cholesterol concentration was higher in the LDC than in the HDC group (P < 0.05). Plasma 3-nitrotyrosine (3-NT) concentration was lower in the LDC than in the HDC group on day 21 post-calving (P < 0.05). Superoxide dismutase activity was higher in the LDC than in the HDC group (P < 0.05). Particularly, in the liver, 3-NT and MDA concentrations were lower in the LDC than in the HDC group (P < 0.05). These results allow inferring that the amelioration of OS biomarkers in plasma and liver could be related to a better reproductive performance of dairy cows.

Evaluation of the relationship between ionized and total calcium concentrations in blood during the first week of lactation in dairy cows

BACKGROUND

Diagnosis of subclinical hypocalcemia in cattle is based on concentration of total Ca ([TCa]) in serum or plasma below the reference range, with [TCa] serving as proxy for the concentration of ionized Ca ([iCa]).

HYPOTHESIS/OBJECTIVES

To investigate the relation between [iCa] and [TCa] in periparturient cows over time, and its association with various metabolites.

ANIMALS

Thirty periparturient dairy cows.

METHODS

Prospective observational study. Blood from periparturient cows was obtained between 4 days before and 7 days after calving. Samples underwent blood gas analysis and blood biochemical analysis. The ratio of [iCa] : [TCa] was computed. Repeated measures linear regression analyses, spearman correlation-, Deming regression- and receiver operating characteristic (ROC) analyses were conducted.

RESULTS

Correlations between [iCa] and [TCa] ranged from r = 0.55 to r = 0.84. The diagnostic value of [TCa] to identify cows with [iCa] below the arbitrary cut-off of 1.1 mmol/L was weak in particular during the first 24 hours of lactation, but continuously improved toward the end of the study with areas under the ROC curve increasing from 0.64 at d 0 to 0.93 at d +4 after calving. Strongest association with [iCa] : [TCa] were found for albumin (r2  = 0.58, P < .0001), pCO2 (r2  = 0.45, P = .0003), the standard [HCO3 ] (r2  = 0.22, P = .01), lactate (r2  = 0.16, P = .04) and [NEFA] (r2  = 0.15, P = .05).

CONCLUSION AND CLINICAL IMPORTANCE

The [TCa] is of limited value to identify cows with subnormal [iCa] in the first hours and days of lactation, a finding apparently attributable to the increased variation of a number of metabolic variables that affect the ratio of [iCa] : [TCa].

Relationship between calcium dynamics and inflammatory status in the transition period of dairy cows

Improvements in nutrition, management, and genetics of dairy cows over the last several decades have shifted research focus from clinical diseases to subclinical disorders, to which transition cows are particularly vulnerable. Recent studies on the characterization of subclinical hypocalcemia (SCH) indicate that the combined analysis of the degree, timing of suboptimal blood Ca concentration, and duration are most reflective of the disorder. Therefore, the understanding of blood Ca dynamics in early postpartum cows has emerged as an avenue to investigate the paths leading to a successful metabolic adaptation to lactation or not. The conundrum has been in defining whether SCH is the cause or a reflection of a greater underlying disorder. Immune activation and systemic inflammation have been proposed to be the root cause of SCH. However, there is a paucity of data investigating the mechanisms of how systemic inflammation can lead to reduced blood Ca concentration in dairy cows. The objective of this review is to discuss the links between systemic inflammation and reduced blood Ca concentration, and studies needed to advance knowledge on the interface between systemic inflammation and Ca metabolism for the transition dairy cow.

Considerations in the Diagnosis and Treatment of Early Lactation Calcium Disturbances

This article reviews the history of clinical hypocalcemia and the evolving definition of subclinical hypocalcemia, targeting a concept for consideration that not all hypocalcemia is negative. With a goal of presenting bovine practitioners information to assist with individual animal hypocalcemia diagnosis and treatment as well as herd-level monitoring and prevention, we present current methods of direct calcium measurement, therapeutic interventions for clinical hypocalcemia, and postpartum calcium supplementation options and their efficacy. We encourage veterinarians to understand calcium dynamics in the immediate postpartum period and evaluate how individual cow therapy and herd prevention protocols can assist with supporting calcium regulation.

Blood calcium concentration and performance in periparturient and early lactating dairy cows is influenced by plant bioactive lipid compounds

Previous studies ex vivo suggested that plant bioactive lipid compounds (PBLC) can increase ruminal calcium absorption. Therefore, we hypothesized that PBLC feeding around calving may potentially counteract hypocalcemia and support performance in postpartum dairy cows. The corresponding aim of the study was to investigate the effect of PBLC feeding on blood minerals in Brown Swiss (BS) and hypocalcemia-susceptible Holstein Friesian (HF) cows during the period from d -2 to 28 relative to calving and on milk performance until d 80 of lactation. A total of 29 BS cows and 41 HF cows were divided each into a control (CON) and PBLC treatment group. The latter was supplemented with 1.7 g/d menthol-rich PBLC from 8 d before expected calving to 80 d postpartum. Milk yield and composition, body condition score and blood minerals were measured. Feeding PBLC induced a significant breed × treatment interaction for iCa, supporting that PBLC increased iCa exclusively in HF cows; the increase was 0.03 mM over the whole period and 0.05 mM from d 1 to 3 after calving. Subclinical hypocalcemia was seen in one BS-CON and 8 HF-CON cows and 2 BS-PBLC and 4 HF-PBLC cows. Clinical milk fever was detected only in HF cows (2 HF-CON and one HF-PBLC). Other tested blood minerals, such as sodium, chloride, and potassium, as well as blood glucose, were neither affected by PBLC feeding nor breed, nor were their 2-way interactions, except for higher sodium levels in PBLC cows on d 21. Body condition score showed no effect of treatment, except for a lower body condition score in BS-PBLC compared with BS-CON at d 14. Dietary PBLC increased milk yield, milk fat yield, and milk protein yield at 2 consecutive dairy herd improvement test days. As indicated by treatment × day interactions, energy-corrected milk yield and milk lactose yield were increased by PBLC on the first test day only, and milk protein concentration decreased from test d 1 to test d 2 in CON only. The concentrations of fat, lactose, and urea, as well as somatic cell count, were not affected by treatment. The weekly milk yield over the first 11 wk of lactation was 29.5 kg/wk higher for PBLC versus CON across breeds. It is concluded that the applied PBLC induced a small but measurable improvement of calcium status in HF cows in the study period and had additional positive effects on milk performance in both breeds.

The association of subclinical hypocalcemia at 4 days in milk with reproductive outcomes in multiparous Holstein cows

Delayed or persistent episodes of subclinical hypocalcemia (SCH) have been associated with reduced milk production and feed intake and they put cows at risk for additional disease development. However, little is known about the effect of delayed or persistent SCH on reproductive outcomes. The objectives of our study were to describe the association between SCH status at 4 d in milk (DIM) with the odds of pregnancy to first service and time to pregnancy through 150 DIM. Data were collected from multiparous Holstein cows (n = 697) from 4 farms in New York State that did not receive supplemental Ca during the first 5 DIM. Cows were classified into 1 of 2 SCH groups based on blood total Ca (tCa) at 4 DIM: normocalcemic (NC; n = 515) if tCa >2.2 mmol/L at 4 DIM or SCH (n = 182) if tCa ≤2.2 mmol/L at 4 DIM. We created a multivariable logistic regression model to assess the association between SCH group and pregnancy to first service and a time-to-event analysis to evaluate the effect of SCH group on the hazard of pregnancy by 150 DIM. Cows that were SCH at 4 DIM had lower odds of pregnancy to first service [odds ratio = 0.75, 95% confidence interval (CI) = 0.61 to 0.93, incidence = 18.1%] compared with their NC counterparts (incidence = 27.4%). Similarly, SCH cows tended to have a lower hazard of pregnancy by 150 DIM (hazard ratio = 0.82, 95% CI = 0.67 to 1.01, incidence = 65.4%) than NC cows (incidence = 70.7%). Our results indicate that delayed or prolonged reductions in blood Ca in the early postpartum period, resulting in SCH at 4 DIM, were associated with reduced reproductive outcomes in multiparous cows. Our findings, in conjunction with previous reports of the negative associations of delayed or persistent SCH on health and production, suggest that reductions in blood Ca beyond the first day of lactation might be indicative of maladaptation to lactation, and the ramifications can persist beyond the immediate postpartum period.

Ursache, Verbreitung und evidenzbasierte Therapie sowie Prävention der peripartalen Hypokalzämie

Die peripartale Hypokalzämie ist eine weit verbreitete Stoffwechselstörung, dessen klinische Form etwa 7 % der Milchkühe und dessen subklinische Form fast jede 2. multipare Kuh betrifft. Obwohl sich hinsichtlich Diagnostik und Therapie in den letzten 30 Jahren kaum etwas verändert hat, herrscht bei Landwirten und Tierärzten Unklarheit über die Prävalenz und den Risikozeitraum dieser Stoffwechselstörung. Darüber hinaus gibt es sehr unterschiedliche Angaben darüber, wieviel Kalzium einer Kuh mit klinischer Hypokalzämie substituiert werden sollte. Ziel dieses Übersichtsartikels ist es, die Entstehung und Verbreitung von Hypokalzämie evidenzbasiert darzustellen. Des Weiteren werden die Ergebnisse älterer und neuer Studien zusammengefast, mit dem Ziel eine möglichst genaue Empfehlung zur Behandlung von klinischer Hypokalzämie zu geben. Da in einer 2017 durchgeführten Studie gezeigt wurde, dass der überwiegende Teil deutscher Milchviehbetriebe keine Prophylaxe gegen Hypokalzämie betreibt, werden in dem letzten Teil dieser Arbeit die verschiedenen Prophylaxekonzepte, unter Berücksichtigung der aktuellen Literatur, dargestellt.

Effect of Negative Energy Balance on Plasma Metabolites, Minerals, Hormones, Cytokines and Ovarian Follicular Growth Rate in Holstein Dairy Cows

Introduction

The aim of this study was to evaluate the effect of negative energy balance (NEB) on the final growth of the dominant ovarian follicle in Holstein cows.

Material and Methods

Cows at 14 to 21 d postpartum from an intensive dairy farm were randomly selected and allocated into a positive energy balance group (PEB, with β-hydroxybutyric acid (BHBA) level < 1.2 mmol/L, n = 15) and an NEB group (BHBA > 1.2 mmol/L, n = 15). Plasma samples were collected at 21, 50 and 55 d postpartum to assess the concentrations of energy metabolites, minerals, hormones and cytokines. Ovaries were examined by transrectal ultrasound on days 50 and 55 (120 hours later) to evaluate the diameter of the largest follicle.

Results

Compared with PEB cows, there were a more severe body condition loss and a lower milk yield in NEB cows (P < 0.05) and these had greater concentrations of plasma BHBA, non-esterified fatty acids, triglycerides, urea nitrogen, growth hormone, interleukin 6, and fibroblast growth factor 21 and lesser concentrations of plasma glucose, total cholesterol, insulin, insulin-like growth factor 1, insulin-like growth factor binding protein 3, leptin, brain-derived neurotrophic factor and angiopoietin-like protein 8 on d 21 (P < 0.05), while plasma minerals were not affected by energy status (P > 0.05). These changes persisted until the end of the study period (50–55 days postpartum) resulting in a lower follicular growth rate for cows in the NEB than the PEB group.

Conclusion

These observations indicate that follicular growth rate is associated with measurable changes in energy metabolite, hormone and cytokine concentrations caused by early postpartum NEB.

Randomized clinical trial to evaluate the effects of a prepartum cholecalciferol injection on postpartum serum calcium dynamics and health and performance in early-lactation multiparous dairy cows

The objectives of the present study were (1) to evaluate the effect of prepartum cholecalciferol treatment on serum Ca concentration during the first 10 d after calving and (2) to evaluate the effect of treatment on subsequent health and performance. Multiparous Holstein cows (n = 377) from one dairy farm were fed a negative dietary cation-anion difference diet (-31 mEq/kg of DM) for the last 21 d of gestation. On d 275, the animals were randomly assigned to a control or a treatment group. Cows in the control group were left untreated, and cows in the treatment group received an injection of 12 × 10⁶ IU of cholecalciferol intramuscularly on the day of enrollment. If treated cows did not deliver the calf within 6 d, they were reinjected with 10 × 10⁶ IU of cholecalciferol. Blood samples were drawn on 1, 2, 3, 5, 7, and 10 days in milk (DIM) and analyzed for serum Ca, P, and Mg concentrations. In a subsample of cows (50 control cows, 35 cows treated once with cholecalciferol, and 15 cows treated twice) serum haptoglobin, nonesterified fatty acids, β-hydroxybutyrate, and 25-hydroxycholecalciferol concentrations were analyzed on 1, 5, and 10 DIM. Binary data [retained placenta (RP), metritis] were analyzed using logistic regression models. Repeated measures ANOVA with first-order autoregressive covariance was performed to evaluate the treatment effect on milk yield over the first 10 test days after parturition, 25-hydroxycholecalciferol, serum Ca, P, Mg, β-hydroxybutyrate, nonesterified fatty acids, and haptoglobin concentrations. Cox proportional hazards were used to model the time to event outcomes (time to pregnancy within 200 d, culling until 300 DIM). After enrollment of 31.4% of cows and a preliminary analysis, adverse reactions became apparent, and the study was stopped. Cows treated with cholecalciferol had a greater risk of incurring RP and metritis. The adjusted mean incidences were 2.0%, 7.7%, and 4.0% for RP, and 21.6%, 39.3%, and 33.3% for metritis for control cows, cows treated once, and cows treated twice with cholecalciferol, respectively. Compared with control cows, cows injected once with 12 × 10⁶ IU of cholecalciferol produced less energy-corrected milk on the first (-3.76 kg) and second (-2.75 kg) test days, respectively. Cows injected twice with cholecalciferol (12 × 10⁶ IU of cholecalciferol and 10 × 10⁶ IU 1 wk later) had a reduced milk yield only at first test day (-3.80 kg). Treatment with cholecalciferol led to a significant increase in 25-hydroxycholecalciferol on d 1, 5, and 10 after calving. Serum Ca and P concentrations were significantly increased in cows treated with cholecalciferol, but serum Mg concentrations were significantly reduced. Haptoglobin concentrations were significantly increased on 5 DIM in cows injected once with 12 × 10⁶ IU of cholecalciferol. Although we observed no effect of treatment on culling until 300 DIM, time to pregnancy was delayed by 34 d in cows injected once with 12 × 10⁶ IU of cholecalciferol. In the present study, injection with 12 × 10⁶ IU of cholecalciferol had detrimental effects on health and milk production despite the beneficial effects on Ca homeostasis.

Effects of restricted dietary phosphorus supply to dry cows on periparturient calcium status

Restricted dietary P supply to transition dairy cows has recently been reported to beneficially affect the Ca balance of periparturient cows. The objective of the present study was to determine whether this effect on the Ca balance can be reproduced when limiting the P-restricted feeding to the last 4 wk of gestation. A total of 30 dairy cows in late pregnancy were randomly assigned to a dry cow diet with either low or adequate P content (0.16 and 0.30% P in DM, respectively) to be fed in the 4 wk before expected calving. After calving, all cows received the same lactating cow ration with adequate P content (0.46% P in DM). Blood was collected daily from 4 d antepartum until calving, at calving (d 0), 6 and 12 h after calving (d +0.25 and d +0.5, respectively) and on days +1, +2, +3, +4 and +7 relative to calving. Blood gas analyses were conducted to determine the concentration of ionized Ca in whole blood ([Ca²⁺]), and plasma was assayed for concentrations of inorganic phosphorus ([Pi]), total calcium, parathyroid hormone ([PTH]), 1,25-dihydroxyvitamin D ([1,25-(OH)₂D₃]), and CrossLaps ([CTX]), a biomarker for bone resorption (Immunodiagnostic Systems GmbH). Repeated-measures ANOVA was conducted to study treatment, time, and lactation number effects. The mean [Ca²⁺] in P-deprived cows remained above the threshold of 1.10 mmol/L throughout the study, and values were higher compared with cows on adequate P supply between d 0 and d +2 and on d +4. The [Ca²⁺] differed between treatments at the sampling times d 0, d +0.25, d +0.5, d +2, and d +4. Plasma [PTH] and [1,25-(OH)₂D₃] did not differ between treatments, but P-deprived cows had greater [CTX] than cows with adequate P supply at d +1, d +2, and d +7. These results indicate that restricted dietary P supply to during the last 4 wk of the dry period improves the Ca homeostasis of these cows in the first days of lactation, an effect that seems to be primarily driven by increased bone tissue mobilization.

Association of low serum calcium concentration after calving with productive and reproductive performance in multiparous Jersey cows

Consequences of postpartum low blood calcium (Ca) concentration are still under study and literature describing this condition in Jersey cows is scarce. A prospective cohort study was conducted to evaluate the association of low serum Ca concentration shortly after calving with milk and energy-corrected milk yields, somatic cell count linear score, and pregnancy to first service and within 150 d in milk in multiparous Jersey cows from 2 commercial herds. Blood samples for serum Ca determination were collected on average at 3 h 10 min postpartum from 352 multiparous Jersey cows. Productive data up to the 10th monthly test were obtained from the Dairy Herd Improvement Association and reproductive data were obtained from herd records. Multiple linear, log-binomial, and Cox's proportional hazards regressions were used to evaluate the association of low serum Ca concentration with productive and reproductive outcomes. Serum Ca concentration ≤2.18 mmol/L was associated with 1.43 and 1.85 kg/d more milk and energy-corrected milk. However, lower serum Ca concentrations were associated with a 0.28-unit-higher somatic cell count linear score per monthly test (Ca ≤2.00 mmol/L), and decreased pregnancy risk at first service (risk ratio = 0.64; Ca ≤1.94 mmol/L) and hazard of pregnancy within 150 d in milk (hazard ratio = 0.40; Ca ≤1.90 mmol/L). The present study is based on a convenience sample of multiparous Jersey cows from 2 commercial herds; further research including more herds and additional blood Ca determinations is needed to describe postpartum blood Ca dynamics and its association with productive and reproductive outcomes for the Jersey breed.

Effects of calcium supplementation, incomplete milking, and vitamin D3 injection on serum total calcium concentration during the first 24 hours after parturition in dairy cows fed an anionic diet during late gestation

OBJECTIVE

To evaluate various strategies for prevention of subclinical hypocalcemia (SH) during the first 24 hours after parturition in dairy cows.

ANIMALS

165 multiparous German Holstein cows from 1 herd.

PROCEDURES

All cows were fed a ration with a moderate dietary cation-anion difference (approx 0 mEq/100 g of dry matter; anionic diet) for the last 2 to 3 weeks of gestation. In the first part of a 2-part study, cows were randomly assigned to 1 of 4 treatment groups (no calcium supplementation [n = 30], oral administration of a calcium bolus alone [34] or in combination with IV administration of 500 mL of a calcium solution [34] or incomplete milking during the first 24 hours after parturition [34]). In part 2, cows in their fifth or greater parity were randomly assigned to receive vitamin D₃ (20,000 U/kg, IM; n = 15) 7 days before the predicted calving date or a control group (18). A calcium bolus was orally administered within 30 minutes after parturition to all cows of part 2. Serum total calcium (Ca_t) concentration was measured immediately after parturition and every 2 hours thereafter for 24 hours and compared among treatment groups. Subclinical hypocalcemia was defined as a Ca_t concentration < 2.00 mmol/L.

RESULTS

In part 1, the mean ± SD Ca_t concentration during the 24 hours after parturition for the IV-treated group (2.28 ± 0.42 mmol/L) was greater than that for the other 3 groups, each of which had a mean Ca_t concentration < 2.00 mmol/L. In part 2, the mean Ca_t concentration for the vitamin D₃-treated cows was greater than that for control cows and remained above 2.00 mmol/L for the duration of the observation period.

CONCLUSIONS AND CLINICAL RELEVANCE

Intramuscular administration of vitamin D₃ or IV administration of a calcium solution in combination with oral administration of a calcium bolus might alleviate SH during the first 24 hours after parturition in dairy cows fed an anionic diet during late gestation.

A Comparison of Rice Husks and Peanut Shells as Bedding Materials on Dairy Cows' Preferences, Behaviour, and Health

Simple Summary

Good bedding materials can increase the comfort potential of the lying surface and enhance the welfare of cows in intensive dairy farms. The preference, behaviour, hygiene, and health of cows are affected by different bedding surfaces. In the current study, we evaluated the preference, behaviour, cleanliness, and health of cows on three bedding materials, peanut shells (PS), rice husks (RH), and a combination of two-thirds peanut shells, one-third rice husk (PRC). The daily behaviour, serum metabolites, and productivity of dairy cows were all within normal values, and no statistical differences were found between all three bedding materials, although cows showed a preference for rice husk when given access to all three bedding materials at the same time. Finally, the results suggest that bedding comprised of peanut shells and peanut–rice combinations are all suitable for maintaining the health and comfort of dairy cows.

Abstract

The provision and quality of bedding materials affect the behaviour, welfare, and health of dairy cows. The objective of this study was to evaluate the preference, behaviour, cleanliness, and physiological status of cows on three bedding materials, peanut shells, rice husks, and a combination of two-thirds peanut shells, one-third rice husk. In an initial experiment, 15 nonlactating, pregnant Holstein cows had free access to all 3 bedding treatments for 39 d. Cows spent more time lying down on rice husk (337 min/d) than on peanut–rice combination (212 min/d) and peanut shell (196 min/d) (p < 0.05), and lay down most often on rice husk (4.35 bouts/d) than on peanut shell (2.55 bouts/d) (p < 0.05) but did not differ between peanut shells and peanut–rice combinations in terms of lying time and lying bouts. In Experiment 2, 12 nonlactating cows were used to assess the effects of the 3 bedding materials on dairy cow behaviour, cleanliness, serum indicators, and productivity. The total duration of lying down (PS: 699.1 min/d, PRC: 645.6 min/d, RH: 852.5 min/d), the frequency of bouts of lying down (PS: 8.7 bouts/d, PRC: 7.6 bouts/d, RH: 11.1 bouts/d), and the mean duration of lying bouts (PS: 83.5 min/bouts, PRC: 91.8 min/bouts, RH: 81.4 min/bouts) did not differ between treatments. Similarly, no differences in eating or drinking behaviour of dairy cows were observed. In terms of hygiene, cleanliness scores did not differ between the three bedding materials, but udder and flank cleanliness decreased and improved, respectively. In addition, treatments did not affect serum metabolites or productivity of the cows. In summary, daily behaviour, serum metabolites, and productivity of dairy cows were all within the normal range, and no statistical differences occurred between the three bedding materials, although cows showed a preference for rice husk when given access to all three bedding materials at the same time. Finally, the results suggest that bedding comprised of peanut shells and peanut–rice combinations are all suitable for maintaining the health and comfort of dairy cows.

Elevated serotonin coordinates mammary metabolism in dairy cows

Serotonin plays a diverse role in maternal and mammary metabolism. Recent research in the dairy cow has shown a relationship between serotonin and calcium, with increased serotonin concentrations improving calcium homeostasis in the peri‐partum dairy cow. Therefore, the objective was to elucidate how administration of 5‐hydroxy‐l‐tryptophan (5‐HTP), the immediate precursor to serotonin, altered serotonin and calcium metabolism in lactating dairy cows. Twelve mid‐late lactation multiparous cows were blocked by parity, production and days in milk and allocated to a daily intravenous infusion of (i) 1.5 mg/kg of 5‐HTP (n = 6) or (ii) saline (n = 6) for 3 consecutive days. Milk samples were collected daily. Blood samples were collected before and after each infusion with mammary biopsies and blood samples collected at 48, 56, and 72 h relative to termination of first infusion. Infusion of 5‐HTP increased (p = 0.001) circulating serotonin concentrations and decreased blood calcium via a transient hypocalcemia immediately after each infusion (p = 0.02). Treatment with 5‐HTP increased milk calcium concentrations (p = 0.02) and calcium release‐activated channel protein 1 (ORAI1) mRNA at 56 h and protein at 48 h relative to termination of first infusion (p = 0.008 and p = 0.09, respectively). Fifty‐six hours from termination of the first infusion mRNA of parathyroid hormone‐related protein and mammary serotonin content were increased relative to control (p = 0.03 and p = 0.05, respectively). These findings demonstrate the ability of 5‐HTP infusion to increase circulating serotonin concentrations and alter endocrine and mammary autocrine/paracrine calcium and serotonin metabolism in the lactating dairy cow.

Graduate Student Literature Review: What do we know about the effects of clinical and subclinical hypocalcemia on health and performance of dairy cows?

This narrative literature review summarizes findings regarding the associations of clinical and subclinical hypocalcemia with postpartum health, reproduction, and milk production. To better understand the effects of hypocalcemia, we reviewed clinical and subclinical presentations of the condition and the dynamics of blood Ca concentration in the early postpartum period. We summarize and discuss the associations between hypocalcemia and performance of dairy cows. Up to 50% of dairy cows suffer from at least one disease event in the transition period. The important roles of calcium in muscle contraction and immune function make it a key component of metabolism, inflammation, and defense against infection. Although the effect of clinical hypocalcemia (milk fever) on health and performance is clear, the definition of subclinical hypocalcemia (SCH) and its consequences for health and performance are still ambiguous. Differences in study designs, sampling protocols, Ca concentration thresholds, and sample sizes that may be underpowered for health and reproduction outcomes lead to inconsistent conclusions on the effects of SCH. On current evidence, classification of SCH should be based on at least 2 measurements of blood calcium, using cutpoints supported with relevant data, which may vary depending on the outcome of interest. Arbitrary or poorly supported interpretative thresholds for blood Ca concentrations should be abandoned. Transient SCH appears to be associated with greater milk yield, whereas SCH that is present several days after calving is associated with lesser production and greater disease risk. However, when blood calcium is measured days after calving, primary effects of calcium metabolism may be confounded by feed intake, inflammation, or disease, which might either contribute to or be a consequence of hypocalcemia. Additional research is needed to refine sampling schemes to classify SCH, and to better inform the goals and means of prevention of SCH.

Association of blood calcium concentration in the first 3 days after parturition and energy balance metabolites at day 3 in milk with disease and production outcomes in multiparous Jersey cows

Research exploring specific associations of markers of negative energy balance and Ca in postpartum Jersey cows with lactation performance is lacking. Our objectives were to evaluate the associations of total Ca concentration (tCa) measured at 1 through 3 d in milk (DIM) and free fatty acids (FFA), β-hydroxybutyrate (BHB), and glucose measured at 3 DIM with (1) the risk of multiparous Jersey cows being diagnosed with early-lactation diseases and culling, (2) milk production in the first 9 wk of lactation, and (3) the risk of pregnancy in the first 150 DIM. A cohort study was performed in 1 dairy herd in Texas. Multivariable Poisson regression models were built to evaluate the association of the analytes of interest with the risks of early-lactation diseases and culling in the first 60 DIM (i.e., binary outcomes). Linear mixed models were used to evaluate the association of the analytes of interest with milk production within the first 9 wk of lactation, and a Cox proportional hazard model was built to assess the risk of pregnancy within 150 DIM. A total of 380 cows were used in the final analyses. Total Ca measured at 1 through 3 DIM was not associated with the risk of metritis. Cows with increased FFA and BHB had an increased risk of being diagnosed with metritis and clinical mastitis, respectively. Increased concentrations of glucose and FFA and decreased tCa at 3 DIM were associated with an increased risk of culling. Reduced tCa concentrations at 1 DIM (≤1.84 mmol/L) and 2 DIM (≤2.04 mmol/L) were associated with increased milk production across the first 9 wk of lactation compared with tCa concentrations above those thresholds. Total Ca was not associated with milk production when assessed at 3 DIM, whereas increased FFA (≥0.37 mmol/L) and decreased glucose (≤2.96 mmol/L) at 3 DIM were associated with increased milk production. None of the metabolites measured were associated with the risk of pregnancy in the first 150 DIM. Our results demonstrate that tCa concentration assessed in the first 3 DIM show temporary associations with milk production and culling in multiparous Jersey cows. Although increased concentration of FFA assessed at 3 DIM was associated with greater milk yield, it was a detrimental factor for the risk of metritis. This study attempted to better elucidate the relationship of tCa, FFA, BHB, and glucose assessed in early postpartum with health and performance of Jersey cows. Based on this study, assessments performed at 3 DIM using tCa concentration ≤1.99 mmol/L for increased risk of early-lactation culling and FFA ≥0.43 mmol/L for increased risk of metritis could be used as starting points. More studies evaluating the dynamics of energy balance markers and tCa in postpartum Jersey cows using a greater number of herds are needed to better inform dairy consultants on critical levels for exacerbated postpartum negative energy balance and subclinical hypocalcemia for the Jersey breed.

Factors That Optimize Reproductive Efficiency in Dairy Herds with an Emphasis on Timed Artificial Insemination Programs

Simple Summary

Reproductive efficiency is critical for profitability of dairy operations. The first part of this manuscript discusses the key physiology of dairy cows and how to practically manipulate this reproductive physiology to produce timed artificial insemination (TAI) programs with enhanced fertility. In addition, there are other critical factors that also influence reproductive efficiency of dairy herds such as genetics, management of the transition period, and body condition score changes and improve management and facilities to increase cow comfort and reduce health problems. Using optimized TAI protocols combined with enhancing cow/management factors that impact reproductive efficiency generates dairy herd programs with high reproductive efficiency, while improving health and productivity of the herds.

Abstract

Reproductive efficiency is closely tied to the profitability of dairy herds, and therefore successful dairy operations seek to achieve high 21-day pregnancy rates in order to reduce the calving interval and days in milk of the herd. There are various factors that impact reproductive performance, including the specific reproductive management program, body condition score loss and nutritional management, genetics of the cows, and the cow comfort provided by the facilities and management programs. To achieve high 21-day pregnancy rates, the service rate and pregnancy per artificial insemination (P/AI) should be increased. Currently, there are adjustments in timed artificial insemination (TAI) protocols and use of presynchronization programs that can increase P/AI, even to the point that fertility is higher with some TAI programs as compared with AI after standing estrus. Implementation of a systematic reproductive management program that utilizes efficient TAI programs with optimized management strategies can produce high reproductive indexes combined with healthy cows having high milk production termed “the high fertility cycle”. The scientific results that underlie these concepts are presented in this manuscript along with how these ideas can be practically implemented to improve reproductive efficiency on commercial dairy operations.

Menthol stimulates calcium absorption in the rumen but not in the jejunum of sheep

Stimulation of Ca²⁺ absorption can counteract hypocalcemia at the onset of lactation. The plant bioactive lipid compound (PBLC) menthol is an agonist for nonselective cation channels of the transient receptor potential (TRP) family. It acutely stimulated Ca²⁺ absorption in ruminal epithelia of nonadapted animals ex vivo and caused higher plasma Ca²⁺ concentrations in cows and sheep in vivo. To elucidate the pathway by which menthol feeding increases plasma Ca²⁺ level, the present study aimed to investigate the long-term dose-dependent effects of dietary menthol-rich PBLC on Ca²⁺ absorption and mRNA abundances of TRP channels in both rumen and jejunum. Twenty-four growing Suffolk sheep were equally distributed to a Con, PBLC-L, and PBLC-H group, which received 0, 80, and 160 mg/d of a menthol-rich PBLC. After 4 wk, ruminal and jejunal epithelia were analyzed for mRNA abundances of TRPA1, TRPV3, TRPV5-6, and TRPM6-8 genes. The Ca²⁺ flux rates and electrophysiological properties of epithelia from rumen and mid-jejunum were measured in Ussing chambers in the presence and absence of mucosal Na⁺. Acute changes in Ca²⁺ flux rates were measured after mucosal application of 50 µM menthol. Ruminal epithelia had quantifiable transcripts of TRPV3 = TRPM6 >TRPM7 >TRPA1 with no difference among feeding groups. Jejunum had quantifiable transcripts of TRPM7 >TRPA1 ≥ TRPM6 ≥ TRPV6 >TRPV5, where TRPA1, TRPV5, and TRPV6 tended to decrease linearly with increasing PBLC dose. Absorptive net flux of Ca²⁺ was detected only in the rumen, whereas jejunum showed a high passive permeability to Ca²⁺. Net flux rates of Ca²⁺ in the rumen increased in a quadratic manner (highest in PBLC-L animals) and were systematically decreased with the omission of mucosal Na⁺. Short-circuit current increased in both PBLC feeding groups compared with Con only in the rumen. Acute application of menthol-stimulated mucosal-to-serosal and net Ca²⁺ flux rates only in ruminal epithelia with higher stimulation in PBLC-fed animals. We conclude that Ca²⁺ transport is mainly active and transcellular in the rumen. It most likely involves TRPV3 that can be stimulated by menthol. Pre-feeding of menthol-rich PBLC enhances ruminal Ca²⁺ absorption and sensitizes it to acute stimulation by menthol. By contrast, intestinal Ca²⁺ absorption is not sensitive to menthol stimulation. Menthol could be used as a tool to enhance ruminal Ca²⁺ absorption and to prevent hypocalcemia in dairy cows.

Association between serum calcium dynamics around parturition and common postpartum diseases in dairy cows

The objective of this study was to compare periparturient serum Ca dynamics (CaDyn) in cows with and without diseases in early lactation. The study enrolled 1,949 cows from a commercial dairy farm in northern Germany. Blood samples were drawn 7 d before expected calving date and on d 0, 1, 3, and 7 after calving and analyzed for serum Ca concentration. Cows were monitored for clinical hypocalcemia (CH), ketosis, left displaced abomasum (LDA), retained placenta, acute puerperal metritis (APM), mastitis, and pneumonia. To evaluate the association between CaDyn and diseases during the transition period, repeated measures ANOVA with first-order autoregressive covariance were performed. Serum CaDyn of healthy cows (i.e., without any of the aforementioned diseases) was compared with CaDyn of cows with one of the aforementioned diseases (CH, ketosis, APM, mastitis, LDA, and pneumonia), and cows with multiple diseases (CH+, ketosis+, APM+, mastitis+, LDA+, and pneumonia+). Separate models were built for primiparous and multiparous cows. For primiparous cows, we evaluated the association between CaDyn and ketosis (healthy cows vs. cows with ketosis vs. cows with ketosis+) and CaDyn and APM (healthy cows vs. cows with APM vs. cows with APM+). The same models were built for multiparous cows. Three additional models were built for multiparous cows to evaluate the association between CaDyn and CH (healthy cows vs. cows with CH vs. cows with CH+), mastitis (healthy cows vs. cows with mastitis vs. cows with mastitis+), or LDA (healthy cows vs. cows with LDA vs. cows with LDA+). In primiparous cows, serum Ca concentrations of cows with ketosis, APM, and APM+ were significantly reduced on d 3 and 7 after calving, compared with healthy cows. Serum Ca concentrations of primiparous cows with ketosis+ were reduced on d 3, but not on d 7 after calving. Multiparous cows with CH had significantly reduced serum Ca concentrations on d 0, 1, and 3 compared with healthy cows. On d 3 and 7, serum Ca concentration of CH+ cows was significantly reduced compared with healthy multiparous cows. Multiparous cows with ketosis and ketosis+ had significantly reduced serum Ca concentrations on d 1 and 3 compared with healthy cows. Cows with APM+ had significantly increased serum Ca concentrations on d 0 and reduced serum Ca concentrations on d 3, compared with healthy cows. Whereas multiparous cows with mastitis had a reduced serum Ca concentration on d 1, mastitis+ cows had a reduced serum Ca concentration on d 1 and 3, compared with healthy multiparous cows. Overall, multiparous cows with LDA+ had reduced serum Ca concentrations. Especially a delayed onset of hypocalcemia (d 3 and 7) was indicative for the development of disease in primiparous cows. In multiparous cows, reduced serum Ca concentrations on d 1 and 3 were associated with occurrence of diseases. Future studies should evaluate whether reduced serum Ca concentrations are a cause or concomitant circumstance of diseases in early lactation.

Cluster analysis to evaluate disease risk in periparturient dairy cattle

Predicting periparturient disease risk is of immense value to the dairy industry. Periparturient diseases are interrelated with each other; however, predicting the onset risk of these diseases has predominantly been based on a single blood parameter for a single disease. This study examined a new diagnostic method to predict the risk of periparturient diseases. We conducted cluster analysis of multiple blood constituents from 20 Holstein cattle at 1 week post-partum, and the cattle were divided into two groups, A or B. We then compared the periparturient and early-lactation blood constituents of these groups. Group B had significantly higher 3-hydroxybutyric acid concentrations and were suspected to have subclinical ketosis. Group B also had significantly lower calcium concentrations, with a tendency for subclinical hypocalcemia. We also performed discriminant analysis using blood parameters at 1 week post-partum, which grouped the population into the same two groups as the cluster analysis based on three variables: inorganic phosphorus, calcium, and either phospholipids or total cholesterol. We further showed that these discriminant functions could be used to predict the risk of periparturient disease even before parturition. Our results indicate that cluster analysis with multiple blood constituents is useful for predicting periparturient disease risks.

Serum biochemical profile in buffalo endometritis and impact of treatment with PGF2α and intrauterine gentamicin infusion on postpartum reproductive performance

Improving reproductive performance of repeat breeder buffalo cows due to clinical endometritis is crucial in overcoming infertility problems in buffalo cows. The aim of the present study was to use PGF2α and/or gentamicin 10% for treatment of endometritis and to determine biochemical parameters in serum that could be used to diagnose endometritis in buffalo cows. A total of 64 anestrous buffalo cows were assigned into one of five treatment groups: group one (n = 9) buffalo cows were physiological normal cows and served as a control group; group 2 buffalo cows had endometritis, but were not treated (n = 10); group 3 buffalo cows had endometritis and were treated with intrauterine delivery of 100 ml of a 10% gentamicin sulfate solution in three times within 1 week (n = 15); group 4 buffalo cows received two I.M. doses of PGF2α (2 ml Estrumate IM) at the time of corpus luteum dominance (n = 15) (treatment 4 does not make sense as you stated that the cows were in anestrus) on the ovary; group 5 buffalo cows received two IM doses of PGF2α at an 11 day interval and the 10% gentamicin solution as described for group 3. Serum samples were collected from control, pre-treated, and post-treated buffalo cows with endometritis to evaluate the diagnostic biochemical parameters. The days to first estrus (DFE), number of services per conception (S/C), days open (DO), and pregnancy rate (Preg) were the measures for determining reproductive performance for the buffalo cows. The buffalo cows treated by gentamicin and PGF2 exhibited their first estrus earlier than cows in the other four groups of cows. The number of days open for control cows was greater (P < 0.05) than for the other groups and the control cows, as were the number of services per conception (P < 0.05) and pregnancy rate (30%: P < 0.05). The receiver operating characteristic (ROC) curve was used to identify biochemical parameters in serum to predict endometritis. Creatine kinase (CK), aspartate aminotransferase (AST), and concentrations of total bilirubin and immunoglobulins in serum were greater (P < 0.05), while serum albumin values were lower (P < 0.05) in serum of buffalo cows with endometritis. From the ROC analyses, CK was the most predictable biomarker for endometritis with an area under the curve of 0.889, sensitivity of 80%, and specificity of 100% (P < 0.001). In conclusion, the use of gentamicin and PGF2 for treatment of endometritis improves the reproductive performance of buffalo cows, and concentrations of CK serve as an aid for diagnosing endometritis.Graphical abstract.

Transition dairy cow health is associated with first postpartum ovulation risk, metabolic status, milk production, rumination, and physical activity

Our objective was to determine the association of health status during the first 60 d in milk (DIM) and first postpartum ovulation risk, physical activities recorded by an activity monitor, and metabolic and milk measures in Holstein cows. Late-gestation heifers and close-up dry cows in 1 herd fitted with CowManager SensOors (Agis, Harmelen, the Netherlands) were enrolled in the study 3 wk before expected parturition to assess ear skin temperature and daily rumination, eating, inactivity, and activity times. Blood samples were collected at calving (d 0), and on d 3, 7, and 14 to assess concentrations of free fatty acids, β-hydroxybutyrate (BHB), calcium, glucose, and haptoglobin. In addition, weekly measures were conducted for body condition, body weight, and progesterone through 63 ± 3 DIM when ovulation was synchronized (GnRH-1 - 7 d - PGF_2α - 24 h - PGF_2α - 32 h - GnRH-2 - 16 h - artificial insemination). Disease diagnosed in 68 of 160 cows (42.5%) was distributed equally between primiparous (48.5%) and multiparous (51.5%) cows. Cows were classified as diseased when any case of metritis, digestive disorders, ketosis, hypocalcemia, calving problems, mastitis, or lameness occurred during the first 60 DIM. Odds of early ovulation by median postpartum d 33 was 1.92 times greater in healthy than diseased cows. Incidence of individual diseases included metritis (18.8%), digestive disorders (17.5%), ketosis (BHB >10 mg/dL; 11.9%), hypocalcemia (Ca <2.2 mmol/L; 10.6%), calving problems (6.3%), mastitis (3.1%), and lameness (3.1%). Odds of early ovulation were 2.48, 2.65, and 5.72 times greater in healthy cows compared with cows diagnosed with metritis, digestive disorders, or ketosis, respectively. Diseased compared with healthy cows had greater concentrations of free fatty acids, BHB, haptoglobin, greater rectal temperature, and lesser concentration of serum calcium on d 0, 3, 7, and 14 than healthy cows. Plasma glucose was not affected by health status, but was lesser in concentration on d 3, 7, and 14 compared with day of calving. Weekly (calving through 9 wk) body condition scores tended to be and weekly body weights were greater in healthy compared with diseased cows. Activity measures differed by health status during prepartum (d -14 through -1) and postpartum (d 0 through 20) periods except for eating time. Healthy cows spent less time being inactive during both periods compared with diseased cows and had greater postpartum rumination times than diseased cows. Mean daily milk yield during the first 14 wk in milk was greater in healthy than diseased cows by 2.1 ± 0.8 kg. We conclude that disease negatively affects early postpartum ovulation risk and is associated with measurable changes in periparturient physical activity and postpartum metabolic profiles.

Effects of maintaining eucalcemia following immunoactivation in lactating Holstein dairy cows

Periparturient hypocalcemia is a common metabolic disorder and it is ostensibly associated with negative health and production outcomes. Acute infection also markedly decreases circulating Ca, but the reasons for and consequences of it on physiological and immunological parameters are unknown. Objectives were to evaluate the effects of maintaining eucalcemia on production, metabolic, and immune variables following an intravenous lipopolysaccharide (LPS) challenge. Twelve multiparous lactating Holstein cows (717 ± 20 kg of body weight; 176 ± 34 d in milk; parity 3 ± 0.2) were enrolled in a study containing 2 experimental periods (P); during P1 (3 d), cows consumed feed ad libitum and baseline values were obtained. At the initiation of P2 (4 d), cows were randomly assigned to 1 of 2 treatments: (1) LPS administered (LPS-Con; 0.5 μg/kg of body weight LPS; n = 6) or (2) LPS administered + eucalcemic clamp (LPS-Ca; 0.5 μg/kg of body weight LPS; Ca infusion; n = 6). Cows were fasted for the first 12 h during P2. After LPS administration, ionized Ca was determined every 15 min for 6 h and every 30 min for an additional 6 h and intravenous Ca infusion was adjusted in LPS-Ca cows to maintain eucalcemia. Blood ionized Ca was decreased 23% for the first 12 h postbolus in LPS-Con cows, and by design, Ca infusion prevented hypocalcemia. To maintain eucalcemia for the 12 h, 13.7 g of Ca was infused. The total Ca deficit (including Ca not secreted into milk) accumulated over the 12 h was 10.4 and 20.2 g for the LPS-Con and LPS-Ca treatments, respectively. Mild hyperthermia (0.8°C) occurred for ∼6 h post-LPS administration relative to P1. From 6 to 7 h postbolus rectal temperature from LPS-Ca cows was increased (0.6°C) relative to LPS-Con cows. On d 1 of P2, milk yield decreased (61%) in both treatments relative to P1. Relative to LPS-Con cows, milk yield decreased (15%) in LPS-Ca cows during P2. Overall, circulating LPS-binding protein continuously increased postbolus, and at 24 h LPS-binding protein levels in LPS-Ca cows were increased (80%) relative to LPS-Con cows. During P2, serum amyloid A increased (4-fold) in both treatments relative to P1. Administering LPS initially decreased circulating neutrophils, then cell counts progressively increased with time. Calcium infusion decreased neutrophil counts (40%) from 9 to 12 h postbolus relative to LPS-Con cows. Neutrophil function, as assessed by oxidative burst and myeloperoxidase production, did not differ due to treatment. In summary, maintaining eucalcemia (via intravenous Ca infusion) during an immune challenge appeared to intensify inflammation and adversely affect lactation performance.

Association of transient, persistent, or delayed subclinical hypocalcemia with early lactation disease, removal, and milk yield in Holstein cows

Our objectives were to evaluate the association of subclinical hypocalcemia (SCH) dynamics with the risk of early lactation disease, removal, and milk production. We conducted a prospective observational cohort study in 407 Holstein cows in 2 dairy herds in New York. Cows were stratified by parity group (144 primiparous, 263 multiparous) and classified into 1 of 4 groups based on postpartum plasma Ca concentrations previously associated with improved milk production or increased risk of disease: normocalcemic (NC; primiparous [Ca] >2.15 mmol/L at 1 and 2 d in milk, n = 67; multiparous [Ca] >1.77 at 1 d in milk and 2.20 mmol/L at 4 d in milk, n = 109); transient SCH (tSCH; primiparous [Ca] ≤2.15 at 1 d in milk and >2.15 mmol/L at 2 d in milk, n = 25; multiparous [Ca] ≤1.77 at 1 d in milk and >2.20 mmol/L at 4 d in milk, n = 50); persistent SCH (pSCH; primiparous [Ca] ≤2.15 mmol/L at 1 and 2 d in milk, n = 33; multiparous [Ca] ≤1.77 at 1 d in milk and ≤2.20 mmol/L at 4 d in milk, n = 34); or delayed SCH (dSCH; primiparous [Ca] >2.15 at 1 d in milk and ≤2.15 mmol/L at 2 d in milk, n = 19; multiparous [Ca] >1.77 at 1 d in milk and ≤2.20 mmol/L at 4 d in milk, n = 70). Evaluated outcomes were development of an adverse event [hyperketonemia (blood β-hydroxybutyrate concentration ≥1.2 mmol/L at 3, 5, 7, or 10 d in milk), metritis, displaced abomasum, or herd removal in the first 60 d in milk] and average milk yield per day across the first 10 wk of lactation. Multivariable Poisson regression was used to analyze the adverse event outcome and generalized linear mixed models for milk yield analysis. Primiparous cows with tSCH were no more likely to have an adverse event than NC cows [risk ratio = 1.3; 95% confidence interval (CI) = 0.5 to 3.2], whereas multiparous cows tended to have a higher risk for an adverse event than NC cows (risk ratio = 1.4; 95% CI = 0.9 to 2.1). However, pSCH cows were 4.1 (95% CI = 2.1 to 7.9, primiparous) and 1.8 (95% CI = 1.2 to 2.7, multiparous) times more likely, and dSCH cows 3.2 (95% CI = 1.5 to 7.0, primiparous) and 1.9 (95% CI = 1.3 to 2.6, multiparous) times more likely, to have an adverse event than NC cows. Primiparous and multiparous cows with tSCH made more milk per day than NC, pSCH, or dSCH cows across the first 10 wk of lactation. Primiparous cows averaged 28.5 ± 0.7, 31.9 ± 1.1, 29.7 ± 0.9, and 28.7 ± 1.2 kg/d, and multiparous cows averaged 44.6 ± 0.7, 49.1 ± 1.1, 46.4 ± 1.3, and 41.4 ± 0.9 kg/d for NC, tSCH, pSCH, and dSCH cows, respectively. Our results suggest that cows with tSCH adapt well to early lactation, develop fewer disease or removal events than pSCH or dSCH cows, and make more milk than NC, pSCH, or dSCH cows. Cows with pSCH or dSCH, regardless of parity group, are at an increased risk for early lactation disease or removal events.

Serum calcium dynamics within the first 3 days in milk and the associated risk of acute puerperal metritis

The objectives of this study were to evaluate postpartum serum calcium dynamics for different parity groups of dairy cows and to assess whether serum calcium concentration on d 0, 1, and 3 postpartum was associated with the risk of developing acute puerperal metritis (APM). The study took place on a commercial dairy farm in northern Germany and included 4,043 Holstein dairy cows. Calving difficulties, such as dystocia, twins, or stillbirth, were recorded. Blood samples were obtained on d 0, 1, and 3 after calving for analysis of serum calcium concentration. Animals were examined daily for clinical symptoms of retained placenta, APM, mastitis, and displaced abomasum until 10 d in milk. To determine serum calcium dynamics postpartum, we performed repeated-measures ANOVA with first-order autoregressive covariance. A logistic regression model was used to evaluate the association of serum calcium concentration with the risk of developing metritis. Serum calcium concentration was affected by time relative to calving, parity, and APM. Increasing parity negatively affected serum calcium concentration on d 0 and 1. Serum calcium concentration reached its lowest level on d 1 and 3 in multiparous and primiparous cows, respectively. The concentration increased from d 1 to 3 in multiparous cows and decreased from d 0 to 3 in primiparous cows. The association of APM and serum calcium dynamics varied by parity. On d 3, serum calcium concentration was significantly lower in animals with subsequent APM than in those without APM. The overall incidence of APM was 12.0% (primiparous cows, 20.4%; multiparous cows, 8.6%). An association existed between serum calcium concentration on d 3 after calving and APM. Primiparous cows had an odds ratio of 0.12 for serum calcium concentration on d 3, indicating that a primiparous cow with serum calcium concentration of 2.5 mmol/L had a 88% lower chance of developing APM compared with a cow with a concentration of 1.5 mmol/L. Multiparous cows had an odds ratio of 0.34 for serum calcium concentration on d 3, indicating that a multiparous cow with serum calcium concentration of 2.5 mmol/L had a 66% lower chance of developing APM compared with a cow with a concentration of 1.5 mmol/L. Primiparous cows with low serum calcium concentration had the highest predicted probability of developing APM. Our results reveal a dynamic in serum calcium concentration in the first 3 d in milk. Consequently, the day of sampling and the observed risk period for hypocalcemia are important when conducting epidemiological studies to evaluate associations between hypocalcemia and clinical diseases.

Cow-level factors associated with subclinical hypocalcemia at calving in multiparous Jersey cows

The objective of our study was to identify cow-level factors associated with subclinical hypocalcemia at calving (SCH) in multiparous Jersey cows. A total of 598 Jersey and 218 Jersey × Holstein crossbreed cows from 2 commercial dairy herds were enrolled in a retrospective cohort study. Blood samples to determine total Ca concentration were collected from the coccygeal vessels at 3 h 19 min (±2 h 33 min) after calving. We used 2 serum Ca concentration thresholds to define SCH: <2.00 mmol/L (SCH-2.00) and <2.12 mmol/L (SCH-2.12). We evaluated the association of cow-level factors with SCH with multivariable Poisson regression models. Variables evaluated for association with SCH were herd; parity (2, 3, and ≥4); breed; previous lactation length and 305-d mature-equivalent milk yield; previous lactation first test milk yield and last test somatic cell count; lengths of calving interval, gestation, dry, and close-up periods; body condition and locomotion scores at calving; calving ease; and calf sex for singletons. We categorized continuous variables into quartiles (≤25th percentile, interquartile range and ≥75th percentile). The prevalence of SCH among Jersey cows was 40 (SCH-2.00) and 64% (SCH-2.12). Jersey cows of higher parity had greater risk of SCH-2.00 and SCH-2.12. The risk of SCH-2.12 was higher after birthing male calves. We also found a tendency for previous lactation length and previous lactation 305-d mature-equivalent milk yield effect to affect risk of SCH-2.12. The risk of SCH-2.12 was lower for cows that had a previous lactation length shorter than the 25th percentile compared with cows that had a previous lactation length within the interquartile range. The risk of SCH-2.12 was higher for cows that had a previous lactation 305-d mature-equivalent milk yield below the 25th percentile compared with cows that had a previous lactation 305-d mature-equivalent milk yield above the 75th percentile. Also, Jersey × Holstein crossbreed was associated with increased risk of SCH-2.00. In the multivariable analysis, we observed no association between SCH and previous lactation first test milk yield; last test somatic cell count; lengths of calving interval, gestation, dry, and close-up periods; body condition and locomotion scores at calving; and calving ease. Our study identified parity, breed, calf sex, previous lactation length, and previous lactation 305-d mature-equivalent milk yield as cow-level factors associated with SCH in multiparous Jersey cows.